PROCEPT BioRobotics (PRCT) Equity Ratio (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Equity Ratio data on file, last reported at 0.71 in Q1 2026.

• Quarterly Equity Ratio fell 4.73% year-over-year to 0.71 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.71 (down 4.73% YoY) and the FY2025 annual result came in at 0.72, down 4.39% from the prior year.
• Equity Ratio slipped to 0.71 in Q1 2026 per PRCT's latest filing, from 0.72 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.79 in Q1 2022 and bottomed at 0.57 in Q2 2023.
• The 5-year median for Equity Ratio is 0.71 (2023), against an average of 0.7.
• The widest annual swing landed in 2023, when Equity Ratio fell 25.61%; it then advanced 17.54% in 2024.
• Tracing PRCT's Equity Ratio over 5 years: stood at 0.64 in 2022, then increased by 8.88% to 0.69 in 2023, then rose by 8.58% to 0.75 in 2024, then dropped by 4.39% to 0.72 in 2025, then slipped by 0.87% to 0.71 in 2026.
• Per Business Quant, the three latest PRCT Equity Ratio figures stand at 0.71 (Q1 2026), 0.72 (Q4 2025), and 0.74 (Q3 2025).

Peer Comparison